SI
RGEN icon

Stephens Inc’s Repligen RGEN Stock Holding History

Stephens Inc’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.7M Buy
48,376
+1,390
+3% +$194K 0.07% 264
2025
Q4 		$7.73M Sell
46,986
-1,852
-4% -$290K 0.1% 213
2025
Q3 		$6.57M Buy
48,838
+1,244
+3% +$151K 0.08% 237
2025
Q2 		$5.92M Buy
47,594
+1,359
+3% +$173K 0.08% 251
2025
Q1 		$5.88M Sell
46,235
-551
-1% -$84.8K 0.09% 245
2024
Q4 		$6.73M Buy
46,786
+86
+0.2% +$12.3K 0.09% 216
2024
Q3 		$6.95M Buy
46,700
+1,680
+4% +$241K 0.1% 213
2024
Q2 		$5.68M Buy
45,020
+4,547
+11% +$713K 0.09% 236
2024
Q1 		$7.44M Sell
40,473
-2,567
-6% -$489K 0.12% 202
2023
Q4 		$7.74M Sell
43,040
-517
-1% -$80.5K 0.13% 178
2023
Q3 		$6.93M Sell
43,557
-1,621
-4% -$265K 0.13% 182
2023
Q2 		$6.39M Buy
45,178
+1,927
+4% +$309K 0.12% 193
2023
Q1 		$7.28M Sell
43,251
-13,925
-24% -$2.48M 0.14% 173
2022
Q4 		$9.68M Buy
57,176
+3,304
+6% +$599K 0.2% 127
2022
Q3 		$10.1M Sell
53,872
-2,023
-4% -$427K 0.22% 109
2022
Q2 		$9.08M Sell
55,895
-502
-0.9% -$79.4K 0.18% 133
2022
Q1 		$10.6M Sell
56,397
-693
-1% -$132K 0.17% 129
2021
Q4 		$15.1M Buy
57,090
+948
+2% +$255K 0.23% 99
2021
Q3 		$16.2M Sell
56,142
-2,561
-4% -$657K 0.25% 89
2021
Q2 		$11.7M Sell
58,703
-239
-0.4% -$46.4K 0.18% 129
2021
Q1 		$11.5M Buy
58,942
+2,239
+4% +$459K 0.19% 119
2020
Q4 		$10.9M Buy
56,703
+439
+0.8% +$79.9K 0.19% 116
2020
Q3 		$8.3M Sell
56,264
-1,323
-2% -$189K 0.16% 135
2020
Q2 		$7.12M Buy
57,587
+1,277
+2% +$150K 0.15% 145
2020
Q1 		$5.44M Buy
56,310
+241
+0.4% +$23.3K 0.14% 158
2019
Q4 		$5.19M Sell
56,069
-2,126
-4% -$179K 0.11% 211
2019
Q3 		$4.46M Buy
58,195
+3,330
+6% +$291K 0.1% 235
2019
Q2 		$4.72M Buy
54,865
+5,159
+10% +$352K 0.11% 219
2019
Q1 		$2.94M Buy
49,706
+62
+0.1% +$3.56K 0.07% 314
2018
Q4 		$2.62M Sell
49,644
-467
-0.9% -$27.4K 0.07% 297
2018
Q3 		$2.78M Buy
+50,111
New +$2.58M 0.07% 326
2017
Q3 		– Sell
-91,977
Closed -$3.81M – 845
2017
Q2 		$3.81M Buy
91,977
+37,756
+70% +$1.43M 0.13% 174
2017
Q1 		$1.91M Sell
54,221
-10,010
-16% -$317K 0.07% 293
2016
Q4 		$1.98M Sell
64,231
-10,475
-14% -$324K 0.08% 268
2016
Q3 		$2.25M Sell
74,706
-22,304
-23% -$673K 0.1% 227
2016
Q2 		$2.65M Buy
97,010
+601
+0.6% +$15.4K 0.12% 183
2016
Q1 		$2.59M Sell
96,409
-10,996
-10% -$269K 0.13% 178
2015
Q4 		$3.04M Sell
107,405
-2,981
-3% -$86K 0.15% 144
2015
Q3 		$3.07M Sell
110,386
-15,091
-12% -$545K 0.16% 136
2015
Q2 		$5.18M Sell
125,477
-13,032
-9% -$477K 0.23% 90
2015
Q1 		$4.21M Sell
138,509
-38,759
-22% -$1.01M 0.19% 121
2014
Q4 		$3.51M Sell
177,268
-145,911
-45% -$3.26M 0.17% 144
2014
Q3 		$6.43M Buy
323,179
+9,381
+3% +$197K 0.32% 57
2014
Q2 		$7.15M Buy
313,798
+252,598
+413% +$4.5M 0.36% 41
2014
Q1 		$787K Sell
61,200
-117,214
-66% -$1.68M 0.04% 367
2013
Q4 		$2.43M Buy
178,414
+28,114
+19% +$336K 0.12% 182
2013
Q3 		$1.67M Buy
150,300
+24,173
+19% +$241K 0.09% 216
2013
Q2 		$1.04M Buy
+126,127
New +$1.06M 0.06% 287

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Stephens Inc's RGEN Position: Q1 2026 in Review

Stephens Inc increased its Repligen (RGEN) stake by 3% in Q1 2026, buying an estimated $194K and bringing the position to 48,376 shares worth $5.7M. The position accounts for 0.07% of the portfolio, ranked #264.

Stephens Inc first reported a position in RGEN in Q2 2013 and has held it in 48 quarters since. The position peaked at $16.2M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Stephens Inc held 48,376 shares of Repligen worth $5.7M as of Q1 2026.
  • Stephens Inc bought 1,390 Repligen shares in Q1 2026, an estimated $194K.
  • Repligen made up 0.07% of Stephens Inc's portfolio in Q1 2026, its #264 holding.
  • Stephens Inc first reported a position in Repligen in Q2 2013 and has held it in 48 quarters since.
  • Stephens Inc's Repligen position peaked at $16.2M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.